Goldman Sachs Analysts: Biggest Risks to COVID Vaccination Targets in US, Europe Are Confidence-Related

Goldman Sachs analysts have updated and expanded their popular research detailing the outlook for vaccine rollout in both the US and internationally. As the FDA prepares to grant the virtually inevitable approval of the Moderna mRNA COVID vaccine later this …

The post Goldman Sachs Analysts: Biggest Risks to COVID Vaccination Targets in US, Europe Are Confidence-Related appeared first on Global Research.